Trial Profile
Prospective study to obtain magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) data in paediatric patients with malignant brain tumour treated with Nimotuzumab
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Nimotuzumab (Primary)
- Indications Brain cancer
- Focus Diagnostic use; Pharmacodynamics
- 10 Dec 2015 New trial record